Consolidated Planning Corp’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.51M Buy
1,261
+27
+2% +$27.6K 0.2% 67
2026
Q1
$1.13M Buy
1,234
+443
+56% +$449K 0.18% 77
2025
Q4
$850K Sell
791
-266
-25% -$254K 0.09% 134
2025
Q3
$806K Buy
1,057
+260
+33% +$193K 0.09% 133
2025
Q2
$621K Sell
797
-296
-27% -$230K 0.08% 135
2025
Q1
$903K Sell
1,093
-95
-8% -$79K 0.12% 114
2024
Q4
$917K Sell
1,188
-4,066
-77% -$3.37M 0.12% 103
2024
Q3
$4.65M Buy
5,254
+2,057
+64% +$1.85M 0.69% 53
2024
Q2
$2.89M Buy
3,197
+2,031
+174% +$1.62M 0.48% 66
2024
Q1
$907K Buy
1,166
+19
+2% +$13.5K 0.16% 91
2023
Q4
$669K Buy
1,147
+141
+14% +$82.3K 0.12% 101
2023
Q3
$540K Sell
1,006
-4
-0.4% -$2.06K 0.12% 104
2023
Q2
$474K Buy
+1,010
New +$424K 0.1% 115
2021
Q4
Sell
-294
Closed -$68K 278
2021
Q3
$68K Buy
+294
New +$72.6K 0.04% 136

Other funds holding LLY

Consolidated Planning Corp's LLY Position: Q2 2026 in Review

Consolidated Planning Corp increased its Eli Lilly (LLY) stake by 2.2% in Q2 2026, buying an estimated $27.6K and bringing the position to 1,261 shares worth $1.51M. The position accounts for 0.2% of the portfolio, ranked #67.

Consolidated Planning Corp first reported a position in LLY in Q3 2021 and has held it in 14 quarters since. The position peaked at $4.65M in Q3 2024. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Consolidated Planning Corp held 1,261 shares of Eli Lilly worth $1.51M as of Q2 2026.
  • Consolidated Planning Corp bought 27 Eli Lilly shares in Q2 2026, an estimated $27.6K.
  • Eli Lilly made up 0.2% of Consolidated Planning Corp's portfolio in Q2 2026, its #67 holding.
  • Consolidated Planning Corp first reported a position in Eli Lilly in Q3 2021 and has held it in 14 quarters since.
  • Consolidated Planning Corp's Eli Lilly position peaked at $4.65M in Q3 2024.
  • 1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Consolidated Planning Corp's 13F filing for Q2 2026, filed 24 Jul 2026.